GlassScriptPhysician profile
Katherine M Owen
NPI 1801407713
$2,358.22
in general payments reported to CMS, 2019-2025
12 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $171 · 2023: $232 · 2024: $1,366 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Travel and Lodging: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,512.59 |
| Travel and Lodging | $544.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,464.62 | 2022-2025 | Minimed 780g |
| Amgen INC. | $182.61 | 2021-2025 | Tepezza, Repatha, Evenity |
| Beta Bionics, INC. | $155.37 | 2024 | Ilet Bionic Pancreas |
| Insulet Corporation | $146.18 | 2023-2025 | Omnipod, Omnipod |
| Dexcom, INC. | $113.54 | 2023-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $81.20 | 2023-2024 | Mounjaro |
| Ascendis Pharma Endocrinology INC | $64.10 | 2025 | Yorvipath |
| Novo Nordisk INC | $63.70 | 2025 | Ozempic, Rybelsus |
| Tandem Diabetes Care, INC. | $28.30 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $22.39 | 2025 | |
| Xeris Pharmaceuticals, INC. | $21.67 | 2024 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $14.54 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.